Axi-Cel Sustains Long-Term Efficacy in R/R Follicular Lymphoma and MZL
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Related Articles
Deep Learning Model for Predicting Immunotherapy Response in Advanced NSCLC
This multicenter cohort study develops and assesses the validity of a deep learning model for predicting immune checkpoint inhibitor response in patients with advanced non−small…
FDA Approval Alert: The Need-to-Know
FDA Approval Alert brings together the most up-to-date information on the latest FDA approvals in oncology. On this page, read, watch, and listen to the…
FDA Approves Subcutaneous Nivolumab in All Solid Tumor Indications
Data from CheckMate-67T support the approval of subcutaneous nivolumab in patients with solid tumors across all previously approved nivolumab indications.
5th How to Diagnose and Treat: Multiple Myeloma | ESH – European School of Haematology
Chairs : Hermann Einsele, Maria Theresa Krauth, Maria Victoria Mateos, Omar Nadeem April 3-5, 2025 – Vienna, Austria Chairs: Hermann Einsele, Maria Theresa Krauth, Maria-Victoria…
Dual immunocytochemical staining of annexin A10 and p53 in low‐grade and papillary urothelial carcinoma contributes to improvement of diagnostic accuracy in urine cytology
Immunostaining for annexin A10 (ANXA10) and p53 was mainly negative in benign urothelium, ANXA10 expression was detected in low-grade urothelial carcinoma, and p53 expression was…
How Ohio State experts brought us closer to a cancer-free world in 2024
2024 was a year of breakthroughs in cancer care, research and knowledge at Ohio State, where oncology experts look ahead to opportunities to innovate in…
A Sense of Culture and Community Sparked a Passion in Genitourinary Oncology
A humble mindset of the contributions he has made to genitourinary cancer care, Christopher J. Logothetis, MD, is also working to shape the next generation’s…
AACR Hematologic Malignancies Research Fellowship
Two year grant of $130,000 for a postdoctoral or clinical research fellow to conduct research projects focused on hematologic malignancies.
Get to Know Moffitt Physician in Chief Dr. Karen Lu
Karen Lu, MD, is a nationally recognized physician-scientist who focuses her clinical and research interests on the surgical and medical treatment of women with ovarian…
In Brief for December 18, 2024 – ILCN.org (ILCN/WCLC)
European Medicines Agency recommends repotrectinib for ROS1-positive NSCLC; FDA approves therapies for NSCLC, LS-SCLC as well as a new diagnostic tool for identifying MET exon…
